Director Bill Vrattos Reports a Big $NEXT Buy

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 NextDecade $NEXT – Director William C. Vrattos filed a Form 4 for $783,236.

Another director added in the LNG developer. Steady, high-conviction accumulation during a corrective wave is something we pay attention to.

📌 BioCryst $BCRX – Deerfield Management’s James Flynn lifted his 13G from 3.00% to 5.80%.

Crossing five percent upgrades this to a meaningful position in biotech. Something to watch for with this healthcare specialist. 

Here’s The Hot Corner, with data from September 19, 2025:

Click the table to enlarge it.

📌 Beta Bionics $BBNX – Millennium Management filed an initial 13G at 5.30%.

📌 Archrock $AROC – Director Jason C. Rebrook filed a Form 4 for $241,670.

Clean insider buy in gas compression. Midstream services bid stays firm as the energy space remains choppy.